bhs beautiful hair and scalp 2 g/100mL
Vibrant Color Anti-dandruff Conditioner · LIQUID · Conopco, Inc. d/b/a/ Unilever
bhs beautiful hair and scalp is a liquid containing vibrant color anti-dandruff conditioner at 2 g/100mL, taken topical. Manufactured by Conopco, Inc. d/b/a/ Unilever.
Key Facts
- Brand Name
- bhs beautiful hair and scalp
- Generic Name
- Vibrant Color Anti-dandruff Conditioner
- NDC Code (Product)
64942-2061- Manufacturer
- Conopco, Inc. d/b/a/ Unilever
- Strength
- 2 g/100mL
- Dosage Form
- LIQUID
- Route
- TOPICAL
- Marketing Status
- Application #
- M032
- Marketing Start
- 08/01/2022
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
Use Helps prevent and control recurrence of itching, flaking and irritation associated with dandruff.
Dosage & Administration
Directions For best results use at least twice per week or as directed by a doctor. Shake well, then massage into scalp and hair. Rinse.
Warnings
Warnings For external use only When using this product avoid contact with eyes. If contact occurs, rinse eyes thoroughtly with water. Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed.
Frequently Asked Questions
What is bhs beautiful hair and scalp used for?
bhs beautiful hair and scalp contains Vibrant Color Anti-dandruff Conditioner. It is a liquid taken topical. Consult your doctor for specific uses.
Is bhs beautiful hair and scalp a controlled substance?
bhs beautiful hair and scalp is not classified as a controlled substance by the DEA.
What is the generic name for bhs beautiful hair and scalp?
The generic name for bhs beautiful hair and scalp is Vibrant Color Anti-dandruff Conditioner. There are no other listed brand versions of Vibrant Color Anti-dandruff Conditioner.
What is the NDC code for bhs beautiful hair and scalp 2 g/100mL?
The NDC (National Drug Code) for bhs beautiful hair and scalp 2 g/100mL is 64942-2061, listed by Conopco, Inc. d/b/a/ Unilever.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)